Making coupons count for patients with HIV
Despite having insurance, too many patients with HIV face high out-of-pocket costs for brand medicines. This is largely driven by insurer-imposed barriers that shift the […]
Despite having insurance, too many patients with HIV face high out-of-pocket costs for brand medicines. This is largely driven by insurer-imposed barriers that shift the […]
Members of Congress continue to push a misguided drug pricing proposal under the guise of negotiation as part of the reconciliation package. This proposal is […]
Members of Congress continue to push a misguided drug pricing proposal under the guise of negotiation as part of the reconciliation package. This proposal is […]
Overall inflation has surged by 9.1% since June of last year. Meanwhile, according to the Bureau of Labor Statistics, prices for prescription medicines grew by […]
Our industry continues working to improve patient access and affordability for medicines at the state level. I recently had the opportunity to connect with PhRMA […]
West Virginia took a big step towards making insurance work like it should last week. As of July 1, thanks to bipartisan state legislation passed […]
A recent Ipsos/PhRMA survey of more than 2,500 registered voters paints a clear picture of health care issues that keep them up at night: insurance […]
In today’s broken insurance system, patients too often pay more for a medicine than what their insurance company pays.
Patient concerns over ever-increasing costs are growing, especially when it comes to their health care. Morning Consult recently conducted a 50-state poll of 20,000 Americans […]
Elizabeth Woodruff drained her retirement account and took on three jobs after she and her husband were sued for nearly $10,000 by the New York […]
Many Americans battle with an illness every day, but unfortunately for some, their illness is not the only battle they face. A recent Morning Consult/PhRMA […]
In comments submitted to the Federal Trade Commission (FTC), PhRMA urged the agency to examine how pharmacy benefit managers (PBMs) leverage their extraordinary power to […]
The COVID-19 pandemic has made clear how important a stable health care system is to the American people, both during times of crisis and beyond. […]
A recent Patient Experience Survey found that Americans with serious chronic conditions, including autoimmune diseases, mental health conditions and neurologic conditions were more likely than […]
Something strange happened between the time Linda Griffith signed up for a new Medicare prescription drug plan during last fall’s enrollment period and when she […]
New data show how robust competition continues to keep national spending on life-saving medicines in check, even as new innovative treatments reach patients. According to […]
The Fierro family of Yuma, Arizona, had a string of bad medical luck that started in December 2020. That’s when Jesús Fierro Sr. was admitted […]
En diciembre de 2020, la familia Fierro, de Yuma, Arizona, comenzó a tener una racha de mala suerte médica. Ese mes, a Jesús Fierro Sr. […]
Today, we’re taking a closer look at Americans’ leading concerns and what issues they want policymakers to prioritize.
A recent study from The Journal of the American Medical Association (JAMA) examined 61 hospitals using data made public under new requirements from a recent […]
According to a new Ipsos/PhRMA poll, most Americans — 82% — agree that lowering out-of-pocket costs for health care should be a top priority for […]
While insurers negotiate steep discounts on medicines, they don’t always share these savings directly with patients. In recent years, insurers have shifted costs for brand […]
Nearly half of insured Americans who take prescription medicines encounter affordability and access barriers to care, according to the findings of the newest installment of […]
Last week, the Senate Finance Committee held a hearing focused on drug prices where the discussion was filled with misleading claims. We agree too many […]
A new study by GlobalData looked at brand oral antidiabetic drugs (OADs) and found that sharing negotiated rebates with patients in commercial health plans at […]
Can’t see the audio player? Click here to listen. Click here for a transcript of the episode. Lillian Karabaic teaches personal finance to millennials through a […]
Concerns about inflation continue to be top of mind for many Americans, as prices for basic services and necessities climb at a rapid pace. But there […]
The second installment of the Patient Experience Survey finds insurer-imposed practices pose significant barriers for Americans as they attempt to access the care they need […]
Did you know Medicaidand the Children’s Health Insurance Program provide health coverage for more than 83 million vulnerable Americans, including children and their parents, pregnant […]
The drug pricing provisions in the Build Back Better Act (BBBA) would allow the government to set the price of certain medicines in Medicare. This […]
PhRMA submitted comments this week in response to the Department of Health & Human Services’ (HHS) 2023 Notice of Benefit and Payment Parameters (NBPP) proposed […]
No one should struggle to afford the medicines they need. Unfortunately, some patients continue to bear more of their medicine costs at the pharmacy counter. […]
As we kick off 2022, Congress has a number of priorities they are aiming to tackle, including the Build Back Better Act (BBBA). Unfortunately, the […]
A new large-scale survey of 20,000 Americans covering all states and Congressional districts shows a majority find health care coverage costs unreasonable and a top […]
More than half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders in 2020 according to a new analysis […]
The federal No Surprises Act, which aims to eliminate unexpected out-of-network medical bills, took effect Jan. 1, and KHN correspondents hit the airwaves to explain […]
Two of the largest lobbying groups representing physicians and hospitals filed a lawsuit Thursday challenging a Biden administration decision on how to implement the law […]
Common-sense reforms can help ensure everyone benefits from America’s engine of innovation and receives the care they need and deserve. In this series, we’re taking […]
Last week, a congressional forum looked at the role pharmacy benefit managers (PBMs) play in determining what patients pay out of pocket for prescription medicines. […]
According to our inaugural Patient Experience Survey (PES), insurance design can jeopardize patients’ health due to access barriers to medicines.
As part of the annual STAT Summit, PhRMA President and CEO Stephen J. Ubl recently spoke with STAT’s Matthew Herper to discuss the many unintended […]
Common-sense reforms can help ensure everyone benefits from America’s engine of innovation and receives the care they need and deserve. In this series, we’re taking […]
As policymakers continue to push partisan drug pricing proposals, several polls misrepresenting voter opinion have been circulated to try and justify these flawed policies. These […]
In September, when Shelly Azzopardi went to Wellstar Kennestone Hospital with abdominal pain, she didn’t worry about her insurance. Doctors said she had a case […]
If you’ve ever had a serious illness or cared for someone who has, you know how quickly the medical bills can pile up: from labs, […]
Common-sense reforms can help ensure everyone benefits from America’s engine of innovation and receives the care they need and deserve. In this series, we’re taking […]
The Medicare prescription drug pricing plan Democrats unveiled this week is not nearly as ambitious as many lawmakers sought, but they and drug policy experts say the […]
America’s biopharmaceutical companies continue to voice the dangers of current proposals in Washington that would allow the government to set prices for medicines. While it’s […]
As the debate in Washington continues on drug pricing, it’s important that policymakers take into account what is actually happening in the market for medicines. […]
3 in 10 insured Americans still face a financial barrier to care and some of the most vulnerable patients are also those more likely to […]
For too many Americans, simply having health insurance isn’t enough to afford and access the care they need. Our inaugural Patient Experience Survey (PES) reveals […]
Today, we released the results in the first report in a series on patient experiences with the health care system. The report, titled “Barriers to […]
This month, PhRMA hosted a media briefing with leaders within the biopharmaceutical industry to discuss the dangers of current proposals on government price setting, while also sharing alternative solutions that […]
Some members of Congress are considering a government “negotiation” plan that would tie medicine prices in Medicare to those in the U.S. Department of Veterans […]
Today, PhRMA member companies made public an open letter to Capitol Hill to encourage Congress to abandon old partisan ideas on drug pricing and instead […]
For years, Ely Bair dealt with migraine headaches, jaw pain and high blood pressure, until a dentist recommended surgery to realign his jaw to get […]
Last month, PhRMA sponsored “Making Medicare Work Better for Patients,” an event hosted by The Hill. During the event, policymakers, patient advocates and biopharmaceutical leaders […]
Policymakers will soon decide whether to stand by new Medicare changes that will help lower costs for beneficiaries at the pharmacy counter or abandon these […]
For 56 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans with certain medical […]
Earlier this year, PhRMA released a proactive agenda with common-sense, patient-centered reforms to improve access to quality, affordable health care. The urgency of building a […]
A recently released report by IQVIA – an independent organization specializing in health care research – provides new data showing prices for brand medicines went down last year. […]
USE OUR CONTENT This story can republished for free. Please contact KHNweb@kff.org for embed codes. Table of Contents A Variety of Services Booming Number of […]
Los ronquidos de José Mendoza eran malos, pero para su esposa Nancy era peor cuando dejaba de respirar. El repentino silencio la despertaba, y si […]
José Mendoza’s snoring was bad — but the silence when he stopped breathing was even worse for his wife, Nancy. The sudden quiet would wake […]
A new study based on IQVIA data shows alarming trends in rising out-of-pocket costs for brand medicines among Medicare Part D beneficiaries with serious and […]
According to a recent survey by Verpora that will be presented this week at ISPOR, nearly half of U.S. payers surveyed expressed a belief that […]
CMS has adopted several new rules that will change how the Affordable Care Act exchanges operate next year. These include rules that will lower out-of-pocket […]
Commercial health insurers are starting to admit what the biopharmaceutical research industry has been warning for some time: copay accumulator adjustment programs hurt patient outcomes […]
In a historic moment for patient affordability, last week West Virginia became the first state in the nation to adopt ground-breaking legislation, HB2263, requiring insurers and […]
A new study published in Health Affairs finds that for nearly 40% of commercially insured patients, half of their annual out-of-pocket expenses for medical treatments […]
When voters cast their ballots in the 2020 election, they made clear their focus on getting COVID-19 under control and fixing the economy. However, health […]
For many patients with complex and chronic conditions, high out-of-pocket costs for medicines pose a significant challenge. Recent research revealed a broken insurance system that […]
When a front group for insurers and drug cost middlemen promote a poll on drug pricing, everyone’s immediate reaction should include a healthy dose of […]
The Senate Finance Committee has released a new report detailing findings of their investigation into the role that market dynamics play in the pricing of […]
While drug middlemen are making billions of dollars in record profits at a time when millions of Americans are facing financial struggles, they are also […]
Can’t see the audio player? Click here to listen on SoundCloud. COVID-19 was the dominant — but not the only — health policy story of 2020. […]
Most Americans tell pollsters they’re worried about being able to afford an unexpected medical bill. Late Monday, Congress passed a bill to allay some of […]
In the 2020 election, Americans nationwide cast their ballots with two major issues on their minds – the economy and coronavirus. Health care specific concerns […]
People buying their own health insurance have even more to think about this year, particularly those post-COVID-19 patients with lingering health concerns, the “long haulers,” […]
As Washington policymakers look to make changes to Medicare and our health care system overall, there are right ways and wrong ways to address the […]
A new analysis by IQVIA looked at three cost-sharing assistance programs and found that from 2018 to 2020, 25% to 36% of patients discontinued treatment […]
Health insurance companies will have to give their customers estimated out-of-pocket costs for prescription drugs and disclose to the public the negotiated prices they pay […]
When Tiffany Qiu heard how much her surgery was going to cost her, she was sure the hospital’s financial department had made a mistake. Qiu, […]
A new study from Xcenda finds that from 2014 to 2020, the number of medicines excluded by at least one of the three largest pharmacy […]
While all eyes and ears are focused on COVID-19 and beating this pandemic, the administration has pursued harmful policy changes that we can’t let slip […]
A recent analysis by IQVIA shows that chronically ill patients who used manufacturer cost-sharing assistance in 2019 saved hundreds to thousands of dollars on their […]
According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas […]
A decade ago, most patients paid only copays for brand medicines. But in recent years, use of deductibles and coinsurance in commercial health plans has […]
Today, IQVIA released a new report, Medicine Spending and Affordability in the U.S., providing context on medicine price and spending trends and patient out-of-pocket costs. The […]
New data show deductibles and coinsurance result in high out-of-pocket spending for commercially insured patients taking brand medicines. IQVIA analyzed trends in cost sharing across […]
A new analysis from IQVIA shows that in 2018, 80% of commercially insured patients attempting to fill a new prescription for a rheumatoid arthritis (RA) […]
Copyright © 2024 | WordPress Theme by MH Themes